Posts By Alex
-
477Wire Stories3-D Secure (3DS) Protections Drive up to 6x Lower Fraud Rates in Regulated Markets According to Latest Datos Insights & Outseer Report
40% of North American FI leaders in 2023 ranked 3DS more effective at fraud detection than other CNP fraud controls compared to...
-
326Wire StoriesTakeda to Present Data at 65th American Society of Hematology (ASH) Annual Meeting, Demonstrating Continued Commitment to Patients with Hematologic Diseases
Company to Feature 17 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology Hematology Presentations Include New Data from the Phase 3...
-
354Wire StoriesThe 5th World Science and Technology Development Forum Opens in Shenzhen
SHENZHEN, China–(BUSINESS WIRE)–On the November 24, the 5th World Science and Technology Development Forum (WSTDF) opened in Shenzhen, Guangdong. Chairman of the...
-
427Wire StoriesKirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!
A special dual-care functional food product from iMUSE, our immune care brand, and Healthya, a visceral fat care brand TOKYO–(BUSINESS WIRE)–Kirin Holdings...
-
573Wire StoriesAPR Achieves Consolidated Sales of KRW 122 Billion and Consolidated Operating Profit of KRW 21.7 Billion in Q3 2023
· Sales increased by 28.0% and operating profit surged by 72.7% year-over-year (YoY) SEOUL, South Korea–(BUSINESS WIRE)–#AGER—APR Corp. (APR, CEO: Byunghoon Kim),...
-
426Wire StoriesFESCARO Emerges as Automotive Cybersecurity Leader with Certification Grand Slam Triumph
Hands-on experience in obtaining all UN R155/156 related certifications Providing a one-stop solution tailored to customers’ needs SMBs and emerging automakers prefer...
-
383Wire StoriesH2SITE and Gold Hydrogen have Signed a MoU for the Development of a Natural Hydrogen Pilot Plant on the Yorke Peninsula, South Australia
• Natural hydrogen is a primary source of energy without carbon footprint. It holds great decarbonization potential. • H2SITE’s technology is an...
-
465Wire StoriesVaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa
A single dose of measles and rubella (MR) vaccine delivered to adults by the Vaxxas high-density microarray patch (HD-MAP) provided antibody responses...
-
415Wire StoriesFPT Software and RWE Strengthen European Strategic Partnership
HANOI, Vietnam–(BUSINESS WIRE)–#FPT–Global technology service provider FPT Software and one of Germany’s leading energy companies, RWE, recently celebrated 10 years of strategic...
-
401Wire StoriesJapan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao
TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led...
